Immunosuppressants Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunosuppressants stocks.

Immunosuppressants Stocks Recent News

Date Stock Title
Jul 1 TEVA Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
Jul 1 TEVA Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 TEVA Teva focus of FTC investigation over inhaler patents
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
Jul 1 CANF Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
Jun 28 AUPH Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) most popular amongst retail investors who own 54% of the shares, institutions hold 35%
Jun 28 TEVA New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Immunosuppressants

Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.In general, deliberately induced immunosuppression is performed to prevent the body from rejecting an organ transplant. Additionally, it is used for treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, or Crohn's disease. This is typically done using medications, but may involve surgery (splenectomy), plasmapheresis, or radiation. A person who is undergoing immunosuppression, or whose immune system is weak for some other reasons (chemotherapy or HIV), is said to be immunocompromised.

Browse All Tags